Showing results (121-130 of 406) with videos related to

Sort By:
Pageof 41
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2018
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.
Arthritis and Rheumatism|April 29, 2006
Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndromeThomas Egerer, Lorena Martinez-Gamboa, Anja Dankof, et al.
Arthritis Research & Therapy|March 13, 2012
The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expressionDaniela Frölich, Daniela Blassfeld, Karin Reiter, et al.
Journal of Periodontology|March 1, 2016
Increased Periodontal Attachment Loss in Patients With Systemic SclerosisNicole Pischon, Daniela Hoedke, Sven Kurth, et al.
Rheumatology (Oxford, England)|September 11, 2021
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritisGerd R Burmester, Vivian P Bykerk, Maya H Buch, et al.
Dermatology (Basel, Switzerland)|March 22, 2006
Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS studyPeter Nash, Diamant Thaçi, Frank Behrens, et al.
Frontiers in Medicine|September 28, 2020
Innovative Imaging Technique for Visualization of Vascularization and Established Methods for Detection of Musculoskeletal Inflammation in Psoriasis PatientsMichaela Köhm, Lukas Zerweck, Phuong-Ha Ngyuen, et al.
RMD Open|September 1, 2025
To optimise the diagnostic process of rheumatic diseases affecting the hands using fluorescence optical imaging (FOI)Nele Stumper, Jörn Berger, Jens Klotsche, et al.
RMD Open|July 3, 2021
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trialClaudia Kedor, Jacqueline Detert, Rolf Rau, et al.
RMD Open|May 28, 2021
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposureGerd R Burmester, Peter Nash, Bruce E Sands, et al.
Pageof 41